Metrics
The numbers behind The Cigna Group: as-reported financial statements and company metrics for FY2021–FY2025, traced to the source filings, opened with the share-price history those statements have to justify. Every linked figure opens the exact page of the filing it was printed on, with the statement row highlighted. Amounts in US$ millions unless noted.
Reading notes: company.json leaves fiscal_year_end blank; The Cigna Group reports on a December 31 calendar-year basis. FY2025 and FY2024 columns are cited to the FY2025 Form 10-K (which prints FY2025/FY2024/FY2023 for the income and cash-flow statements and FY2025/FY2024 for the balance sheet). FY2023 and FY2022 columns are cited to the FY2023 Form 10-K; FY2021 income-statement and cash-flow figures are the LDTI-restated comparative column of the FY2023 Form 10-K. The FY2021 balance sheet column is taken from the FY2021 Form 10-K on the pre-LDTI basis — no LDTI-restated FY2021 balance sheet is printed anywhere in the corpus (the FY2023 10-K balance sheet shows only FY2023 and FY2022). FY2021/FY2022 income and cash-flow figures are restated; treat the FY2021 balance sheet as on a slightly different (pre-LDTI) basis.
Share Price — Full Available History — 37 Years
The stock closed at $284.85 on Jul 22, 2026 — up 4,158% over the window shown (+10.8% a year), trading between $3.74 and $366.85. At that close the stock trades at 13× FY2025 diluted EPS as reported below.
Source: market price feed, monthly closes, sampled from 9,206 source observations, Jan 1990–Jul 2026. Price return only, excludes dividends.
Market capitalization $74.0bn.
Market cap = 259.6M shares outstanding × the Jul 22, 2026 close of $284.85. Market-derived, shown without filing links.
FY2025 at a Glance
Revenue (US$ millions)
Net income (US$ millions)
Diluted EPS
Source: FY2025 consolidated statements [1] [2]. Click any linked figure to open the filing page with the row highlighted.
Total Revenues by Segment
| Total Revenues by Segment | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Evernorth Health Services | 131,912 | 140,335 | 153,499 | 201,973 | 234,953 |
| Cigna Healthcare | 44,643 | 44,911 | 51,148 | 53,118 | 47,412 |
| Other Operations | 3,989 | 2,263 | 596 | 828 | 674 |
| Corporate and Eliminations | (6,475) | (6,991) | (9,978) | (8,798) | (8,139) |
| Total revenues | 174,069 | 180,518 | 195,265 | 247,121 | 274,900 |
| Total revenues growth, derived | — | +3.7% | +8.2% | +26.6% | +11.2% |
Source: Note to the Consolidated Financial Statements — Segment Information (total revenues by reportable segment) [3] [4] [5] [6]. Click any linked figure to open the filing page with the row highlighted.
Segment Pre-Tax Adjusted Income from Operations
| Segment Pre-Tax Adjusted Income from Operations | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Evernorth Health Services | 5,818 | 6,127 | 6,442 | 7,001 | 7,221 |
| Cigna Healthcare | 3,601 | 4,099 | 4,478 | 4,229 | 4,153 |
| Other Operations | 903 | 509 | 96 | (9) | 89 |
| Corporate and Eliminations | (1,339) | (1,466) | (1,698) | (1,688) | (1,593) |
| Total pre-tax adjusted income from operations | 8,983 | 9,269 | 9,318 | 9,533 | 9,870 |
Source: Note to the Consolidated Financial Statements — Segment Information (pre-tax adjusted income (loss) from operations) [3] [4] [5] [6]. Click any linked figure to open the filing page with the row highlighted.
Income Statement
Source: Consolidated Statements of Income [1] [2]. Click any linked figure to open the filing page with the row highlighted.
Columns marked E are consensus analyst estimates from S&P Capital IQ (CapIQ), shown alongside reported results for direct comparison; they are not company guidance.
Estimate source: S&P Capital IQ (CapIQ) consensus, as of 2026-07-22. Estimate figures are S&P Capital IQ consensus (vendor data — no filing page links). EPS and net income use the normalized (adjusted) consensus where the street reports it. Line-item analyst models (segments, drivers, KPIs) are in the Visible Alpha tab.
Balance Sheet
Source: Consolidated Balance Sheets [7] [8] [9]. Click any linked figure to open the filing page with the row highlighted.
Cash Flow
Source: Consolidated Statements of Cash Flows [10] [11]. Click any linked figure to open the filing page with the row highlighted.
Cigna Healthcare — Insurance Operating Metrics
| Cigna Healthcare — Insurance Operating Metrics | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total medical customers (thousands) | 17,081 | 18,004 | 19,780 | 19,147 | 18,118 |
| Insured medical customers (thousands) | 4,757 | 4,756 | 5,464 | 5,064 | 3,808 |
| Administrative services only (ASO) customers (thousands) | 12,324 | 13,248 | 14,316 | 14,083 | 14,310 |
| Medical care ratio | 84.0% | 81.7% | 81.3% | 83.2% | 84.4% |
| Cigna Healthcare pre-tax adjusted margin | 8.1% | 9.1% | 8.7% | 8.0% | 8.8% |
Source: company filings [12] [13] [14]. Click any linked figure to open the filing page with the row highlighted.
Evernorth Health Services — Pharmacy Services Metrics
| Evernorth Health Services — Pharmacy Services Metrics | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Pharmacy claim volume / adjusted scripts (millions) | 1,638 | 1,575 | 1,585 | 2,120 | 2,222 |
| Evernorth pre-tax adjusted margin | 4.4% | 4.4% | 4.2% | 3.5% | 3.1% |
| Evernorth SG A / adjusted expense ratio | 1.9% | 2.0% | 2.2% | 1.9% | 1.8% |
Source: company filings [15] [16] [17]. Click any linked figure to open the filing page with the row highlighted.
Consolidated Earnings, Dividends Leverage
| Consolidated Earnings, Dividends Leverage | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Adjusted income from operations (after-tax) | 6,982 | 7,313 | 7,448 | 7,741 | 8,014 |
| Adjusted income from operations per share (diluted) | 20.48 | 23.36 | 25.09 | 27.33 | 29.84 |
| Dividends declared per share | 1.00 | 1.12 | 1.23 | 1.40 | 1.51 |
| Debt-to-capitalization ratio | 41.7% | 41.0% | 40.1% | 43.8% | 43.0% |
Source: company filings [18] [19] [20] [21]. Click any linked figure to open the filing page with the row highlighted.
Long-Term Record
| Fiscal year | Total revenue | Shareholders' net income | Diluted earnings per share | Net cash from operating activities | Total shareholders' equity |
|---|---|---|---|---|---|
| FY2016 | 39,838 | — | — | — | — |
| FY2017 | 41,806 | — | — | — | — |
| FY2018 | 48,650 | — | — | — | — |
| FY2019 | 153,566 | 5,104 | 13.44 | 9,485 | — |
| FY2020 | 160,401 | 8,458 | 22.96 | 10,350 | 50,321 |
| FY2021 | 174,069 | 5,370 | 15.75 | 7,191 | 47,112 |
| FY2022 | 180,518 | 6,704 | 21.41 | 8,656 | 44,675 |
| FY2023 | 195,265 | 5,164 | 17.39 | 11,813 | 46,223 |
| FY2024 | 247,121 | 3,434 | 12.12 | 10,363 | 41,033 |
| FY2025 | 274,900 | 5,957 | 22.18 | 9,601 | 41,713 |
Source: consolidated statements across filings; older years from the standardized feed [10] [7] [1] [11]. Click any linked figure to open the filing page with the row highlighted.
Analyst Consensus
Mean target
Median target
High target
Low target
Street ratings: 15 strong buy, 5 buy, 4 hold. Consensus: Buy.
Estimate source: S&P Capital IQ (CapIQ) consensus, as of 2026-07-22. Estimate figures are S&P Capital IQ consensus (vendor data — no filing page links). EPS and net income use the normalized (adjusted) consensus where the street reports it. Line-item analyst models (segments, drivers, KPIs) are in the Visible Alpha tab.
Traceability
369 of 372 figures on this page (99%) link to the filing page where they are printed — click a linked figure to open the source PDF at that page with the row highlighted. Unlinked figures come from standardized data feeds or pre-filing years.
company.json leaves fiscal_year_end blank; The Cigna Group reports on a December 31 calendar-year basis.
FY2025 and FY2024 columns are cited to the FY2025 Form 10-K (which prints FY2025/FY2024/FY2023 for the income and cash-flow statements and FY2025/FY2024 for the balance sheet).
FY2023 and FY2022 columns are cited to the FY2023 Form 10-K; FY2021 income-statement and cash-flow figures are the LDTI-restated comparative column of the FY2023 Form 10-K.
The FY2021 balance sheet column is taken from the FY2021 Form 10-K on the pre-LDTI basis — no LDTI-restated FY2021 balance sheet is printed anywhere in the corpus (the FY2023 10-K balance sheet shows only FY2023 and FY2022). FY2021/FY2022 income and cash-flow figures are restated; treat the FY2021 balance sheet as on a slightly different (pre-LDTI) basis.
Revenue breakdown and segment profit use Cigna's reported segment structure (Evernorth Health Services, Cigna Healthcare, Other Operations, Corporate and Eliminations). FY2021–FY2022 segment figures are the recast comparatives disclosed in the FY2023 10-K segment footnote; the FY2025 10-K segment footnote is presented under ASU 2023-07 with pre-tax adjusted income (loss) from operations as the segment profit measure.
FY2016–FY2018 long-term figures (Cigna Corporation, before the December 2018 Express Scripts acquisition) come from the standardized SEC XBRL data feed and are shown without page links; net income and diluted EPS are not available in the feed for those years. The step-up in total revenue from FY2018 (~48.7bn) to FY2019 (153.6bn) reflects the Express Scripts acquisition.
Quarterly income-statement and balance-sheet cells are taken directly from the printed 10-Q statements (single-quarter/three-month income columns; point-in-time balance sheets). Quarterly cash-flow single quarters are derived from the printed year-to-date statements and cross-check exactly to data/financials/cash_flow_quarterly.json (Q2 FY25 operating cash flow -1,886; Q3 FY25 3,418). A Q4 FY25 quarter is omitted because no separate Q4 statement is filed (Q4 data is the FY2025 annual).
3 figure(s) differed between the data feed and the filing; the filing value is shown (see the run's metrics/metrics_tab.json for the audit trail).